Sign in Subscribe
Cancer

Real-World Pharmacological Treatment Patterns of Neuropathic Pain in China

Strategic Insights

— 1 min read

Research conducted at Peking University Cancer Hospital and Institute in Beijing, People's Republic of China, has shed light on the real-world pharmacological treatment patterns of neuropathic pain in China. The study, planned to involve approximately 600 patients with diabetic peripheral neuropathic pain (DPNP) and 400 with chemotherapy-induced peripheral neuropathy (CIPN), aimed to describe demographics, clinical characteristics, and treatment patterns of these patients.

Key Takeaways:

  • The study focused on DPNP and CIPN, which are common subtypes of neuropathic pain, imposing a significant clinical burden on patients and affecting their quality of life.
  • The research employed a multicenter, retrospective, observational design, using electronic medical record (EMR) systems from nine hospitals, with a study period from January 1, 2017, to December 31, 2022.
  • The primary objective of the study was to describe demographics, clinical characteristics, and treatment patterns, including types and proportion of treatment regimens, treatment discontinuation/switching/add-on, restarting after discontinuation, duration of index regimen, and time to treatment add-on.
  • The secondary and exploratory measures of the study included the dosing pattern and real-world adherence of regimens.
  • The study's observation period was defined as the period from the index date to the end of the study data collection for at least 12 months.

Statistics:

  • Approximately 600 patients with DPNP and 400 with CIPN were to be included in the study.
  • The study period extended from January 1, 2017, to December 31, 2022.
  • The observation period was defined as the period from the index date to the end of the study data collection for at least 12 months.

Sources:

  • Peking University Cancer Hospital and Institute, Beijing, People's Republic of China
  • Springer Int Publ Ag, Gewerbestrasse 11, Cham, Ch-6330, Switzerland (publisher of Pain and Therapy journal)
  • NewsRx LLC, 2025.

Read more